Comparing two ways to measure kidney function in advanced kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at two different ways of measuring kidney function in people with advanced kidney disease who are either about to start or are already on dialysis. It will compare a simple blood test estimate to a more accurate measure to see which is more practical and useful for guiding care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Either expected to start dialysis within 6 months, or already on dialysis with some remaining kidney function (more than about half a cup of urine per day)
- Able to give consent and follow English instructions
- No allergy to contrast dye
- Not pregnant or breastfeeding, and no planned kidney transplant within the next month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better assess how well kidneys recover after acute kidney injury (a sudden loss of kidney function during hospitalization). You may be asked to participate in interviews, workshops, or have some medical measurements taken to help improve patient care.
This study tests whether a special CT scan can measure kidney function accurately in people with reduced kidney function. You may already need this scan for other reasons, and the research will see how well the scan works as a kidney test.
This study looks at whether a special way of measuring kidney function during your emergency CT scan can help predict if the contrast dye might harm your kidneys. If you are having an emergency CT with contrast, this study could help doctors watch for kidney problems early.
This study compares two ways of measuring kidney function in ICU patients with a sudden kidney injury. The results will help doctors know which method is better for adjusting treatments.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
This trial tests a new fluorescent dye that may help doctors quickly check how well your kidneys are working while you are in the intensive care unit. It could provide a faster, less invasive way to monitor kidney health.
Hear when a new Chronic Kidney Disease (Stages 4 and 5) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.